SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-24-008287
Filing Date
2024-05-15
Accepted
2024-05-15 16:05:43
Documents
81
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q adap-20240331x10q.htm   iXBRL 10-Q 1285927
2 EX-31.1 adap-20240331xex31d1.htm EX-31.1 9822
3 EX-31.2 adap-20240331xex31d2.htm EX-31.2 10565
4 EX-32.1 adap-20240331xex32d1.htm EX-32.1 6132
5 EX-32.2 adap-20240331xex32d2.htm EX-32.2 6114
  Complete submission text file 0001558370-24-008287.txt   6566038

Data Files

Seq Description Document Type Size
6 EX-101.SCH adap-20240331.xsd EX-101.SCH 51359
7 EX-101.CAL adap-20240331_cal.xml EX-101.CAL 65058
8 EX-101.DEF adap-20240331_def.xml EX-101.DEF 201697
9 EX-101.LAB adap-20240331_lab.xml EX-101.LAB 425252
10 EX-101.PRE adap-20240331_pre.xml EX-101.PRE 322175
85 EXTRACTED XBRL INSTANCE DOCUMENT adap-20240331x10q_htm.xml XML 1111305
Mailing Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX
Business Address 60 JUBILEE AVENUE MILTON PARK ABINGDON, OXFORDSHIRE X0 OX14 4RX 44 1235 430000
Adaptimmune Therapeutics PLC (Filer) CIK: 0001621227 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37368 | Film No.: 24950403
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)